Inrobics Company Profile

Background

Inrobics Social Robotics, S.L.L., established in 2020 as a spin-off from the Carlos III University of Madrid, specializes in digital health solutions that integrate social robotics and artificial intelligence (AI). The company's mission is to enhance the quality of rehabilitation treatments by intensifying, personalizing, and adapting therapies to individual needs, thereby improving patient motivation and outcomes. Inrobics envisions creating products that positively impact people's quality of life, contributing to a more inclusive future.

Key Strategic Focus

Inrobics focuses on developing innovative rehabilitation solutions for individuals with motor, cognitive, or social impairments resulting from conditions such as cerebral palsy, stroke, and Alzheimer's disease. The company offers two primary products:

Inrobics Rehab Clinic: Designed for clinical settings, this solution features a humanoid social robot that interacts with patients through therapeutic games, monitored by 3D cameras and heart rate bracelets.

Inrobics Rehab Virtual: A remote rehabilitation tool that allows patients to complete therapist-designed clinical therapies at home using a tablet with proprietary software.

Operating on a B2B model, Inrobics partners with hospitals, rehabilitation centers, nursing homes, and insurers across Europe, targeting mid-to-large facilities within the health, wellness, and education sectors.

Financials and Funding

Inrobics has secured funding through various channels:

Early Stage VC (August 2022): Raised €355,500 in a pre-seed funding round.

Accelerator/Incubator (May 2024): Participated in an accelerator/incubator program to further develop its offerings.

Notable investors include Grow Venture Partners, Capital Cell, and Impulse2grow.

Technological Platform and Innovation

Inrobics distinguishes itself through its proprietary technologies and innovative methodologies:

ALMA Software: This AI-driven software animates robots, enabling them to interact with patients and healthcare professionals. ALMA utilizes machine learning to adapt to each user's needs, facilitating personalized therapy sessions.

Social Robotics: The company's solutions employ social robots to engage patients in therapeutic activities, enhancing motivation and adherence to treatment plans.

Data Analytics: Inrobics' platforms collect and analyze patient performance data in real-time, providing clinicians with objective assessments to monitor progress and adjust therapies accordingly.

Leadership Team

José Carlos Pulido, PhD: Co-Founder & CEO. Dr. Pulido holds a PhD in Computer Science and Technology from the Universidad Carlos III de Madrid and an MBA in Digital Health Management. With over a decade of experience in AI and social care robotics, he has conducted research at the University of Southern California and the Karlsruher Institut für Technologie.

José Carlos González, PhD: Co-Founder & CTO. Dr. González earned his PhD in Computer Science and Technology from the Carlos III University of Madrid, specializing in AI and robotics. He has over ten years of experience in IT architectures and has conducted research at Carnegie Mellon University and the Karlsruher Institute for Technology.

Fernando Fernández, PhD: Co-Founder & CSO. Dr. Fernández is a professor of computer science at the Carlos III University of Madrid and former CEO of Adact Solution SL. He has published over 50 scientific articles on AI and has international research experience at Carnegie Mellon University and the University of Texas at Austin.

Competitor Profile

Market Insights and Dynamics

The rehabilitation robots market is experiencing significant growth, driven by advancements in AI and robotics, an aging population, and increasing demand for effective rehabilitation solutions.

Competitor Analysis

Key competitors in the rehabilitation robotics sector include:

H Robotics: Develops the rebless robot, a physical therapy device focusing on upper and lower extremities, providing treatment through various training modes.

Adamo Robot: Offers a collaborative robot capable of treating musculoskeletal disorders by applying pressurized air to imitate manual massage therapy techniques.

Capsix Robotics: Designs autonomous body care devices like the iYU, an autonomous massage device used by physiotherapists and health clinics.

Strategic Collaborations and Partnerships

Inrobics collaborates with various healthcare institutions and research centers to enhance its product offerings and expand its market reach. These partnerships focus on integrating Inrobics' solutions into clinical practice and validating their effectiveness in real-world settings.

Operational Insights

Inrobics' strategic considerations include:

Market Position: By offering both clinical and home-based rehabilitation solutions, Inrobics addresses a broad spectrum of patient needs, enhancing its market presence.

Competitive Advantages: The integration of social robotics and AI, along with a focus on patient engagement and data-driven therapy, differentiates Inrobics from competitors.